Naoya Yamazaki

76PUBLICATIONS
206CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Medical mycologyNgā taonga Māori nō mua (Māori artefacts)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (76)

|Sep 07, 2026
Three Cases of Merkel Cell Carcinoma Treated With Lutetium-177 Oxodotreotide.

|Mar 03, 2026
Efficacy and safety of pazopanib in patients with paclitaxel-pretreated primary cutaneous angiosarcoma in Japan: Results of the Japan Clinical Oncology Group single-arm confirmatory trial (JCOG1605).

Kohei Oashi, Dai Ogata, Masayuki Yokoyama

|Jan 15, 2026
Exploratory Analysis of Biomarkers and Treatment Outcomes from the COLUMBUS Study in BRAF V600E/K-Mutant Advanced or Metastatic Melanoma.

Reinhard Dummer, Shibing Deng, Tao Xie

|Dec 31, 2025
Real-World Efficacy of Chemotherapy in Patients With Advanced Unresectable Extramammary Paget Disease: A Retrospective Multicenter Study of 138 Japanese Patients.

Azusa Miyashita, Satoshi Fukushima, Koji Yoshino

|Dec 05, 2025
Treatment Outcomes of Surgery and ICI Therapy in 52 Patients With Esophageal Melanoma: A Retrospective Single-Center Cohort Study.

Akihiro Ishiguro, Dai Ogata, Koshiro Ishiyama

|Oct 08, 2025
Real-World Efficacy and Safety of MEK Inhibitor for Patients With Advanced NRAS-Mutant Melanoma: A Single-Center Retrospective Study in Japan.

Eiji Nakano, Yuta Kage, Dai Ogata

Pageof 13

Frequent Collaborators

43 joint publications

Kenjiro Namikawa

29 joint publications

Dai Ogata

25 joint publications

Eiji Nakano

7 joint publications

Yusuke Muto